H3B-6527 |
H3B-6527 |
Phase 1 Clinical |
H3 Biomedicine |
Liver Neoplasms; Cholangiocarcinoma; Carcinoma, Hepatocellular |
Details
|
Roblitinib |
FGF-401; NVP-FGF401 |
Phase 2 Clinical |
Novartis Pharma Ag |
Solid tumours; Neoplasms; Carcinoma, Hepatocellular |
Details
|
ICP-105 |
ICP-105 |
Phase 1 Clinical |
Beijing Tiancheng Pharmaceutical Technology Co Ltd, Nanjing Tianyin Jianhua Pharmaceutical Technology Co Ltd, Beijing Innocare Pharma Tech Co Ltd |
Solid tumours; Liver Neoplasms |
Details
|
BPI-43487 |
BPI-43487 |
Phase 1 Clinical |
Betta Pharmaceuticals Co Ltd |
Biliary Tract Neoplasms; Solid tumours; Carcinoma, Hepatocellular |
Details
|
Fisogatinib |
BLU-554; CS-3008 |
Phase 2 Clinical |
Blueprint Medicines Corp |
Carcinoma, Hepatocellular |
Details
|
PRN-1371 |
PRN-1371 |
Phase 1 Clinical |
Principia Biopharma Inc |
Solid tumours; Urinary Bladder Neoplasms |
Details
|
SY-4798 |
|
Phase 1 Clinical |
Shouyao Holding (Beijing) Co Ltd |
Solid tumours |
Details
|
ZSP-1241 |
ZSP-1241 |
Phase 1 Clinical |
Guangdong Zhongsheng Pharmaceutical Co Ltd, Wuxi Apptec Co Ltd |
Liver Neoplasms; Biliary Tract Neoplasms; Stomach Neoplasms; Carcinoma; Esophageal Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Carcinoma, Hepatocellular |
Details
|
HS-236 |
HS-236 |
Phase 1 Clinical |
Zhejiang Hisun Pharmaceutical Co Ltd |
Solid tumours |
Details
|
Aldafermin |
M-70; NGM-282 |
Phase 2 Clinical |
Ngm Biopharmaceuticals |
Constipation; Liver Cirrhosis, Biliary; Non-alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2; Renal Insufficiency; Fibrosis; Cholangitis, Sclerosing; Hepatic Insufficiency; Diabetes Mellitus |
Details
|
EVER-4010001 |
EVER-4010001 |
Phase 2 Clinical |
Yunyan Pharmaceutical Technology (Zhuhai Hengqin) Co Ltd |
Solid tumours |
Details
|
ABSK-011 |
ABSK-011 |
Phase 2 Clinical |
Abbisko Therapeutics |
Liver Neoplasms; Solid tumours; Carcinoma, Hepatocellular |
Details
|
Futibatinib |
TAS-120 |
Phase 3 Clinical |
Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd |
Bone Marrow Neoplasms; Solid tumours; Stomach Neoplasms; Carcinoma; Esophageal Neoplasms; Carcinoma, Transitional Cell; Central Nervous System Neoplasms; Breast Neoplasms; Cholangiocarcinoma; Lymphoma; Carcinoma, Non-Small-Cell Lung |
Details
|